WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo
YH Park, HS Kim, D Lee, MB Lee, KY Min… - Toxicology and Applied …, 2019 - Elsevier
YH Park, HS Kim, D Lee, MB Lee, KY Min, MG Jo, JE Lee, YM Kim, WS Choi
Toxicology and Applied Pharmacology, 2019•ElsevierMast cells (MCs) play an important role as effector cells that cause allergic responses in
allergic diseases. For these reasons, MC is considered an attractive therapeutic target for
allergic disease treatment. In this study, we investigated the inhibitory effect of WZ3146, N-[3-
[5-chloro-2-[4-(4-methylpiperazin-1-yl) anilino] pyrimidin-4-yl] oxyphenyl] prop-2-enamide,
and the mechanisms of its actions on the MC activation and IgE-mediated allergic response
by using three types of MCs such as rat basophilic leukemia (RBL)-2H3 cells, mouse bone …
allergic diseases. For these reasons, MC is considered an attractive therapeutic target for
allergic disease treatment. In this study, we investigated the inhibitory effect of WZ3146, N-[3-
[5-chloro-2-[4-(4-methylpiperazin-1-yl) anilino] pyrimidin-4-yl] oxyphenyl] prop-2-enamide,
and the mechanisms of its actions on the MC activation and IgE-mediated allergic response
by using three types of MCs such as rat basophilic leukemia (RBL)-2H3 cells, mouse bone …
Abstract
Mast cells (MCs) play an important role as effector cells that cause allergic responses in allergic diseases. For these reasons, MC is considered an attractive therapeutic target for allergic disease treatment. In this study, we investigated the inhibitory effect of WZ3146, N-[3-[5-chloro-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide, and the mechanisms of its actions on the MC activation and IgE-mediated allergic response by using three types of MCs such as rat basophilic leukemia (RBL)-2H3 cells, mouse bone marrow mast cells (BMMCs), and human Laboratory of Allergic Diseases 2 (LAD2) cells. WZ3146 inhibited antigen-stimulated degranulation in a dose-dependent manner (IC50, ~ 0.35 μM for RBL-2H3 cells; ~ 0.39 μM for BMMCs; ~ 0.41 for LAD2 cells). WZ3146 also suppressed the production of histamine, tumor necrosis factor (TNF)-α and interleukin (IL)-6, which mediate various allergic responses, in a dose-dependent manner. As the mechanism of WZ3146 to inhibit MCs, it inhibited the activation of spleen tyrosine kinase (Syk) and the downstream signaling proteins of Syk such as linker for activation of T cell (LAT) and phospholipase (PL) Cγ1 in the signaling pathway of FcεRI. In addition, WZ3146 inhibited the activation of Akt, extracellular signal-regulated kinase (ERK)1/2, p38, and c-Jun N-terminal kinase (JNK). However, WZ3146 did not inhibit degranulation of MCs by thapsigargin or ionomycin, which increase calcium concentration in cytosol. Notably, WZ3146 inhibited the activity of Lyn and Fyn, but not Syk. In an following animal experiment, WZ3146 inhibited IgE-dependent passive cutaneous anaphylaxis (PCA) in a dose-dependent manner (ED50, ~ 20 mg/kg). Taken together, in this study we show that the pyrimidine derivative, WZ3146, inhibits the IgE-mediated allergic response by inhibiting Lyn and Fyn Src-family kinases, which are initially activated by antigen stimulation in MCs. Therefore, we propose that WZ3146 could be used as a new therapeutic agent for the treatment of allergic diseases.
Elsevier